Artemis Medicare Services Limited (NSE:ARTEMISMED)
India · Delayed Price · Currency is INR 273.15
-3.85 (-1.39%)
Jul 13, 2026, 10:10 AM IST
Artemis Medicare Services Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Artemis Medicare Services stock has a consensus rating of "Strong Buy" and an average price target of ₹330.25. The average 1-year stock price forecast is 20.90% higher than the current stock price, while the lowest is ₹316.00 (+15.69%) and the highest is ₹340.00 (+24.47%).
Price Target: ₹330.25 (+20.90%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Artemis Medicare Services stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 3 | 4 |
Financial Forecast
Revenue This Year
13.34B
from 10.81B
Increased by 23.36%
Revenue Next Year
16.93B
from 13.34B
Increased by 26.91%
EPS This Year
8.33
from 6.71
Increased by 24.29%
EPS Next Year
12.43
from 8.33
Increased by 49.20%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 |
|---|---|---|
| High | 13.9B | |
| Avg | 13.3B | |
| Low | 12.0B |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 28.1% | |
| Avg | 23.4% | |
| Low | 11.3% |
EPS Forecast
| EPS | 2027 | 2028 |
|---|---|---|
| High | 9.00 | |
| Avg | 8.33 | |
| Low | 7.80 |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | 34.2% | |
| Avg | 24.3% | |
| Low | 16.3% |